- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/155 - Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (HN=C(OH)NH2), isothiourea (HN=C(SH)—NH2)
Patent holdings for IPC class A61K 31/155
Total number of patents in this class: 2787
10-year publication summary
|
235
|
243
|
263
|
262
|
239
|
287
|
295
|
249
|
188
|
45
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Boehringer Ingelheim International GmbH | 4629 |
69 |
| Rani Therapeutics, LLC | 184 |
41 |
| The Regents of the University of California | 18943 |
30 |
| Sanovel Ilac Sanayi ve Ticaret A.S. | 257 |
26 |
| Sanofi-Aventis Deutschland GmbH | 2738 |
25 |
| Anji Pharmaceuticals Inc. | 38 |
25 |
| The Catholic University of Korea Industry-academic Cooperation Foundation | 631 |
17 |
| Novartis AG | 11238 |
16 |
| Immunomet Therapeutics Inc. | 30 |
15 |
| Neoculi Pty Ltd | 18 |
15 |
| Solventum Intellectual Properties Company | 2681 |
15 |
| The General Hospital Corporation | 4517 |
13 |
| Innovation Technologies, Inc. | 32 |
13 |
| Nusirt Sciences, Inc. | 42 |
13 |
| Bristol-myers Squibb Company | 5080 |
12 |
| University of Florida Research Foundation, Inc. | 3883 |
12 |
| Hanall Biopharma Co., Ltd. | 93 |
12 |
| National Cancer Center | 292 |
12 |
| United Kingdom Research and Innovation | 354 |
12 |
| Board of Regents, The University of Texas System | 5370 |
11 |
| Other owners | 2383 |